| |
Course Director
_____________________________________________
 Sarah Blair, MD
Associate Clinical Professor, Surgery
Tumor Growth, Invasion & Metastasis Program
UC San Diego Moores Cancer Center
San Diego, CA
Planning Chair
_____________________________________________
Adriana Vela NanoTumor Center Project Leader
Founder & Chair, NanoTecNexus
San Diego, CA
......
Course Faculty
_____________________________________________
| |
Sadik Esener, PhD
Principal Investigator and Center Director, NanoTumor Center;
Professor, Electrical & Computer Engineering,
UC San Diego School of Engineering
San Diego, CA |
|
Liangfang Zhang, PhD
Professor, Department of Nanoengineering,
UC San Diego Moores Cancer Center
San Diego, CA |
| |
Piotr Grodzinski, PhD
Director,
NCI Alliance for Nanotechnology in Cancer
Office of the Director
National Cancer Institute
Bethesda, MD
|
|
Bradley Messmer, PhD
Assistant Project Scientist, Translational Oncology Program,
UC San Diego Moores Cancer Center
San Diego, CA |
| |
Robert Mattrey, MD
Professor, Radiology
Tumor Growth, Invasion & Metastasis Program
UC San Diego Moores Cancer Center
San Diego, CA |
|
Eric Murphy, PhD
Assistant Project Scientist
Tumor Growth, Invasion & Metastasis Program
UC San Diego Moores Cancer Center
San Diego, CA |
| |
Mike Heller, PhD
Professor, Electrical & Computer Engineering, Bioengineering, Nanoengineering
UC San Diego School of Engineering
San Diego, CA |
|
|
Faculty Disclosure
________________________________________________________________________________
It is the policy of the University of California , San Diego School of Medicine to ensure balance, independence, objectivity and scientific rigor. All persons involved in the selection, development and presentation of content are required to disclose any real or apparent conflicts of interest. All conflicts of interest will be resolved prior to an educational activity being delivered to learners through one of the following mechanisms 1) altering the financial relationship with the commercial interest, 2) altering the individual’s control over CME content about the products or services of the commercial interest, and/or 3) validating the activity content through independent peer review. All persons are also required to disclose any discussions of off label/unapproved uses of drugs or devices. Participants will be asked to evaluate whether the speaker’s outside interests reflect a possible bias in the planning or presentation of the activity. This information is used to plan future activities.
|
|
| |

University of California, San Diego School of Medicine
Continuing Medical Education
9500 Gilman Drive, MC0617, La Jolla, Ca 92093-0617
Phone: (858) 534-3940 Toll-Free (888) 229-OCME (6263) Fax: (858) 534-7672
E-mail: ocme@ucsd.edu Website: http://cme.ucsd.edu
For technical comments or questions, contact the webmaster
Copyright 2010, University of California, San Diego. All rights reserved.
|
|